DNA X, Inc. Income Statement
SONM|6 years of annual SEC 10-K data (FY2019-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 6 fiscal years. All figures from audited SEC 10-K filings.
DNA X, Inc. reported $94M in revenue and $90,000 in net loss for FY2024. Revenue has declined at a 7.1% compound annual rate over the past 5 years.
Based on SEC 10-K filings.
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Revenue | $93.6M | $69.8M | $54.6M | $64.0M | $116.3M | $135.7M |
| Cost of Revenue | $74.3M | $58.2M | $48.2M | $48.8M | $81.7M | $87.6M |
| Gross Profit | $19.3M | $11.6M | $6.4M | $15.2M | $34.5M | $48.1M |
| SG&A Expense | $8.3M | $10.7M | $10.3M | $9.8M | $15.1M | $7.2M |
| R&D Expense | $1.8M | $8.0M | $17.7M | $16.2M | $26.1M | $23.2M |
| Operating Income | $513.0K | -$14.3M | -$38.0M | -$29.3M | -$22.4M | $5.4M |
| Interest Expense | - | - | $97.0K | - | - | - |
| Income Tax | $374.0K | $184.0K | $167.0K | -$521.0K | $1.4M | $754.0K |
| Net Income | -$90.0K | -$14.1M | -$38.6M | -$29.9M | -$25.8M | $1.3M |
| EPS (Basic) | -$0.02 | -$0.49 | -$4.08 | - | - | - |
| EPS (Diluted) | -$0.02 | -$0.49 | - | -$6.48 | -$1.39 | -$2.57 |
| Shares Outstanding | 4.4M | 40.8M | 18.8M | 6.6M | 20.4M | 15.6M |
| Gross Margin | 20.6% | 16.7% | 11.8% | 23.8% | 29.7% | 35.4% |
| Operating Margin | 0.5% | -20.5% | -69.6% | -45.7% | -19.3% | 4.0% |
| Profit Margin | -0.1% | -20.2% | -70.8% | -46.8% | -22.2% | 0.9% |